Table 2.
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
RR | 95 % CI | P-value | RR | 95 % CI | P-value | |
Age | 1.149 | 0.3154 – 4.190 | 0.8328 | 1.162 | 0.1601 – 4.622 | 0.8607 |
FIGO stage | 1.877 | 0.4963 – 7.102 | 0.3535 | 2.524 | 0.2284 – 27.89 | 0.4501 |
Lymph node metastasis | 1.937 | 0.5174 – 7.248 | 0.3263 | 1.197 | 0.4152 – 8.85 | 0.4044 |
Parametrium invasion | 3.155 | 0.9579 – 11.76 | 0.0681 | 1.716 | 0.0402 – 8.416 | 0.691 |
Margin positive | 3.884 | 0.3645 – 685.0 | 0.1581 | 1.604 | 0.03867 – 10.06 | 0.7392 |
Primary tumor > 4 cm | 0.3786 | 0.05758 – 1.266 | 0.1609 | 0.3811 | 0.2314 – 29.76 | 0.4362 |
Serum SCC antigen > 5.0 ng/mL | 0.6878 | 0.1982 – 2.365 | 0.5545 | 0.2663 | 0.04308 – 1.646 | 0.1545 |
LVSI | 8.698 | 1.508 – 18.00 | 0.011* | 9.764 | 0.7944 – 120.0 | 0.07506 |
Shrinkage rate ≦ 50 % | 6.098 | 2.328 – 37.18 | 0.0021* | 12.14 | 1.023 – 144.1 | 0.04794* |
RR Relative risk, CI Confidence interval, Univariate analysis, Log rank test; Multivariate analysis, Cox proportional hazard model; *significant p-value